5% stakes
Kynam Capital Management
Institution
- 5% stake reports
- 18
- 5% stake stocks
- 9
- Latest report
- 26/08/14
5% stake reports
| Stock | ||
|---|---|---|
| Viridian Therapeutics, Inc.\DE VRDN08/14 | 5.7%0 sh | +4.2pp |
| Vera Therapeutics VERA08/14 | 4.01%0 sh | −1.4pp |
| CytomX Therapeutics CTMX08/14 | 9.96%0 sh | +3.1pp |
| Celldex Therapeutics CLDX08/14 | 6.78%0 sh | −2.0pp |
| Burning Rock Biotech BNR05/15 | 13.97%0 sh | +3.0pp |
| Celldex Therapeutics CLDX05/15 | 8.77%0 sh | −1.0pp |
| CytomX Therapeutics CTMX05/15 | 6.9%0 sh | +1.6pp |
| Sutro Biopharma STRO05/15 | 5.27%0 sh | −1.2pp |
| CytomX Therapeutics CTMX03/04 | 5.29%8,966,077 sh | First report |
| Cullinan Therapeutics CGEM03/04 | 5.27%3,114,132 sh | First report |
| Viridian Therapeutics, Inc.\DE VRDN02/17 | 1.54%1,470,541 sh | −4.2pp |
| enGene Therapeutics ENGN02/17 | 2.23%1,492,898 sh | −7.6pp |
| Cogent Biosciences COGT02/17 | 4.33%6,165,223 sh | −1.2pp |
| Vera Therapeutics VERA25/08/14 | 5.37%3,426,887 sh | First report |
| Celldex Therapeutics CLDX25/05/15 | 9.79%6,500,000 sh | +2.2pp |
| Viridian Therapeutics, Inc.\DE VRDN25/05/15 | 5.76%0 sh | First report |
| Sutro Biopharma STRO25/05/15 | 6.44%0 sh | First report |
| enGene Therapeutics ENGN25/02/14 | 9.8%4,994,090 sh | First report |
